Back to Job Search
Expired
  • Salary: £26000 - £30000 per annum, Benefits: 15% bonus, pension, life insurance, health insurance, 25 days holiday
  • Job Type:Permanent

Posted about 3 years ago

  • Sector: Clinical Operations
  • Contact: James Hume
  • Contact Email: james.hume@nextphaserecruitment.com
  • Contact Phone: 01403 216216
  • Start Date: 2021-02-04
  • Job Ref: V-46628

 Summary:

This is an opportunity for an Associate Scientist to join a company who are committed to harnessing the unique properties of their T Cell technology to revolutionise the world of immunotherapies.  This is an influential role where you will be contributing to, and influencing, the design of experimental programmes for the charcterisation of T Cell therapies.

The Opportunity:

As an Associate Scientist, you will laboratory based with a focus on the execution of experimental programmes to support the development and qualification of analytical methods for the support of R&D and GMO Manufacture.

  • Perform laboratory-based activities as part of experimental programmes for the development of assays and their qualification.

  • Provide support for the development of assays such as ELISA or Flow Cytometry

  • Ensure all experiments are completed in line with project timelines,

  • Work in close collaboration with internal and external stakeholders.

  • Ensure all work is completed in like with company procedures and are documented properly.



Required Skills & Expertise:

You will need:

  • A MSc or BSc or A - levels and subsequent experience in the Cell Therapy, ATMP, Biopharma, or Biologics sectors for example

  • Laboratory based experience of cell culture,

  • Experience of cell-based assays, and flow cytometry,

  • Experience of using PCR,

  • Experience of working in a commercial environment,

The Company:

The company are a leading T Cell Therapy company who have developed a specific technology to harness their unique properties that is set to revolutionise the world of immunotherapies and the lives of patients.  Their mission is to deliver allogenic using unique properties of specific T cells that provide additional benefits to the survival of patients suffering from cancer.  These cells are more effective because they do not target healthy tissues but eradicate infectious or cancerous cells by triggering a response through the adaptive immune system.  They now have therapies at pre clinical stages which are set to progress to clinical trials plus focusing on the development of new immunotherapies as they explore the potential of their technology.


As a company they have offer excellent career progression opportunities with a strong learning & development focus and roles where you gain exposure to develop your career.  With a collaborative environment where they are committed to the delivery of life changing cancer therapies to improve patient’s lives.